Molecular Biomarkers & Diagnosis

Biomarkers in Liquid Biopsy: Revolutionizing the Diagnosis of Lung Cancer and Beyond

Abstract

Richard Nguyen*

Liquid biopsy has emerged as a revolutionary technique in the diagnosis, monitoring, and treatment of various cancers, particularly lung cancer. Unlike traditional biopsy methods, which involve invasive tissue extraction, liquid biopsy relies on non-invasive sampling of bodily fluids such as blood, urine, or saliva to detect cancer-associated biomarkers. This technique has gained significant attention due to its ability to provide real-time insights into tumor dynamics and genetic alterations without the need for tissue samples.